Skip to Content
Merck
CN
  • Inactivation of peptidylglycine α-hydroxylating monooxygenase by cinnamic acid analogs.

Inactivation of peptidylglycine α-hydroxylating monooxygenase by cinnamic acid analogs.

Journal of enzyme inhibition and medicinal chemistry (2015-05-30)
Neil R McIntyre, Edward W Lowe, Matthew R Battistini, James W Leahy, David J Merkler
ABSTRACT

Peptidylglycine α-amidating monooxygenase (PAM) is a bifunctional enzyme that catalyzes the final reaction in the maturation of α-amidated peptide hormones. Peptidylglycine α-hydroxylating monooxygenase (PHM) is the PAM domain responsible for the copper-, ascorbate- and O2-dependent hydroxylation of a glycine-extended peptide. Peptidylamidoglycolate lyase is the PAM domain responsible for the Zn(II)-dependent dealkylation of the α-hydroxyglycine-containing precursor to the final α-amidated peptide. We report herein that cinnamic acid and cinnamic acid analogs are inhibitors or inactivators of PHM. The inactivation chemistry exhibited by the cinnamates exhibits all the attributes of a suicide-substrate. However, we find no evidence for the formation of an irreversible linkage between cinnamate and PHM in the inactivated enzyme. Our data support the reversible formation of a Michael adduct between an active site nucleophile and cinnamate that leads to inactive enzyme. Our data are of significance given that cinnamates are found in foods, perfumes, cosmetics and pharmaceuticals.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Phenylpropiolic acid, 99%